Sanofi (SNY) Inventory Average (2018)

Sanofi (SNY) posted Inventory Average of $4.3 billion for Q4 2018, up 2723.43% sequentially from $153.8 million in Q3 2018.

Sanofi (SNY) Inventory Average (2018) Analysis & Trends

Sanofi (SNY) has 1 years of Inventory Average data on file, last reported at $4.3 billion in Q4 2018.

Quarterly Inventory Average changed N/A year-over-year to $4.3 billion in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $4.3 billion (changed N/A YoY) and the FY2025 annual result came in at $11.0 billion, up 6.98% from the prior year.
Inventory Average climbed to $4.3 billion in Q4 2018 per SNY's latest filing, from $153.8 million in the prior quarter.
The five-year high for Inventory Average was $8.3 billion in Q1 2018, with the low at $153.8 million in Q3 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inventory Avg. (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn	14.14 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn	14.39 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn	5.00 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn	6.56 Bn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn	6.57 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn	6.21 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn	1.84 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn	10.66 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-	-
10	Sanofi	-	-	9.49 Bn	-

Download Data